• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Syra Health Secures $660,000 Population Health Contract Extension

    3/13/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $SYRA alert in real time by email

    CARMEL, Ind., March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization. This agreement, combined with the previous year's agreement, brings the total contract value up to $1.32 million.

    Syra Health - A catalyst for improving health outcomes. (PRNewsfoto/Syra Health)

    "We are pleased to continue securing valuable population health contract extensions, as demonstrated by this announcement," said Dr. Deepika Vuppalanchi, Chair and CEO of Syra Health. "This is a testament to the trust our partners place in us and highlights our ongoing ability to deliver impactful healthcare solutions that improve health outcomes. As we continue to secure such extensions, we are confident in our strategy to deliver long-term growth, expanded reach, and sustainable value creation."

    Through the contract extension, Syra Health's team will continue providing Healthcare Effectiveness Data and Information Set (HEDIS®) outreach and support services. This extension enables Syra Health to further contribute to the organization's efforts to improve healthcare quality, enhance member outcomes, and reduce costs through expert data analysis and member outreach initiatives, as initially announced in March of 2024.

    This contract extension supports the continued expansion of Syra Health's Population Health business unit, which is one of the key growth contributors to the company's diversifying revenue base. The success and renewal of these contracts align with Syra Health's strategic focus of strengthening its revenue streams through higher-margin business segments.

    About Syra Health

    Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Contacts

    For Media Inquiries:

    Christine Drury

    Corporate Communications Director

    Syra Health

    463-345-5180

    [email protected]

    For Investor Inquiries:

    Corbin Woodhull

    Managing Director, Global Advisory

    Hayden IR

    602-476-1821

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-secures-660-000-population-health-contract-extension-302400525.html

    SOURCE Syra Health

    Get the next $SYRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SYRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SYRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Syra Health Corp.

      SC 13G - Syra Health Corp (0001922335) (Subject)

      2/20/24 3:01:17 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    Financials

    Live finance-specific insights

    See more
    • Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

      Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

      5/8/25 7:55:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • Syra Health To Discuss First Quarter 2025 Financial Results

      Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

      5/1/25 8:55:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

      2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

      3/11/25 7:43:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    SEC Filings

    See more
    • Syra Health Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Syra Health Corp (0001922335) (Filer)

      5/20/25 4:30:24 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • Syra Health Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Syra Health Corp (0001922335) (Filer)

      5/8/25 4:45:37 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Syra Health Corp.

      10-Q - Syra Health Corp (0001922335) (Filer)

      5/8/25 4:30:29 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

      CARMEL, Ind., May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site. The contract is valued at $5.8 million over three years, with an optional one-year extension. Syra has committed to subcontracting 23.5% of the total contract value to other Indian

      5/27/25 8:55:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • Syra Health Board Begins CEO Search to Drive Growth

      CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

      5/20/25 9:00:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

      Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

      5/8/25 7:55:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

      4 - Syra Health Corp (0001922335) (Issuer)

      9/13/24 9:10:53 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    Leadership Updates

    Live Leadership Updates

    See more
    • Syra Health Board Begins CEO Search to Drive Growth

      CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

      5/20/25 9:00:00 AM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary

    $SYRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Rogers Sherron

      4 - Syra Health Corp (0001922335) (Issuer)

      1/8/25 8:39:45 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • SEC Form 4 filed by Director Dahlem Andrew

      4 - Syra Health Corp (0001922335) (Issuer)

      1/8/25 8:39:48 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary
    • SEC Form 4 filed by Director Paranjape Ketan

      4 - Syra Health Corp (0001922335) (Issuer)

      1/8/25 8:39:43 PM ET
      $SYRA
      Diversified Commercial Services
      Consumer Discretionary